|
|
| The Only Multiple Award-Winning Brand in the Industry |
|
| www.PharmExec.com features easy-to-use navigation with content available by targeted category, keyword search, or by issue. Fresh content supplied by Pharmaceutical Executive’s expert staff as well as external sources make PharmExec.com the source for comprehensive information and essential insight. |
|
| Reserve Your Premium Position in the January Issue! |
 |
| » Ad Space Close: Dec. 7 |
|
|
| » Ad Materials Due: Dec. 13 |
|
|
| FEATURES |
Market Access in Latin America:
Challenges and Opportunity
Pharm Exec Editor-in-Chief William Looney convenes a panel of executives responsible for the Latin America business to discuss investment, market access and reimbursement issues in this key regional growth market for biopharma companies. Organizing the market access function to address the diversity of local health system infrastructure and practice patterns is highlighted.
Annual Industry Outlook
Pharm Exec explores the key trends shaping the industry’s scientific potential, commercial performance, and reputational assets in 2017, including a special section on managing political risk.
Supply Chain Roundup
Pharm Exec’s annual feature looks at the latest approaches in managing logistics and supply chain activities to best reap cost-efficiencies and complement new global market penetration strategies. The piece also explores how companies can prepare for new regulations that will alter the way pharmaceuticals are packaged and shipped.
The State of Market Insights
A survey on the changing role of the market research function within life science companies reveals several pivot-points with impact on the function’s ability to perform at a time of historic M&A levels and regulatory uncertainty—where the industry needs timely, quantified market insight more than ever.
|
|
Content subject to change |
|
| 2017 Media Kit |
| Included in our comprehensive print and electronic media planner is all of the information you will need to help you formulate your marketing plans for 2017. |
| |
 |
|
|
|
|
|
|
